首页> 外文OA文献 >Development of Multifunctional Liposomes Containing Magnetic/Plasmonic MnFe2O4/Au Core/Shell Nanoparticles
【2h】

Development of Multifunctional Liposomes Containing Magnetic/Plasmonic MnFe2O4/Au Core/Shell Nanoparticles

机译:含有磁性/等离子体MNFE2O4 / Au芯/壳纳米粒子的多功能脂质体的研制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multifunctional liposomes containing manganese ferrite/gold core/shell nanoparticles were developed. These magnetic/plasmonic nanoparticles were covered by a lipid bilayer or entrapped in liposomes, which form solid or aqueous magnetoliposomes as nanocarriers for simultaneous chemotherapy and phototherapy. The core/shell nanoparticles were characterized by UV/Visible absorption, X-Ray Diffraction (XRD), Transmission Electron Microscopy (TEM), and Superconducting Quantum Interference Device (SQUID). The magnetoliposomes were characterized by Dynamic Light Scattering (DLS) and TEM. Fluorescence-based techniques (FRET, steady-state emission, and anisotropy) investigated the incorporation of a potential anti-tumor drug (a thienopyridine derivative) in these nanosystems. The core/shell nanoparticles exhibit sizes of 25 ± 2 nm (from TEM), a plasmonic absorption band (λmax = 550 nm), and keep magnetic character. XRD measurements allowed for the estimation of 13.3 nm diameter for manganese ferrite core and 11.7 nm due to the gold shell. Aqueous magnetoliposomes, with hydrodynamic diameters of 152 ± 18 nm, interact with model membranes by fusion and are able to transport the anti-tumor compound in the lipid membrane, with a high encapsulation efficiency (EE (%) = 98.4 ± 0.8). Solid magnetoliposomes exhibit hydrodynamic diameters around 140 nm and also carry successfully the anticancer drug (with EE (%) = 91.2 ± 5.2), while also being promising as agents for phototherapy. The developed multifunctional liposomes can be promising as therapeutic agents for combined chemo/phototherapy.
机译:开发了含有锰铁素体/金芯/壳纳米颗粒的多功能脂质体。这些磁性/等离子体纳米颗粒被脂质双层覆盖物或夹在脂质体中,其形成固体或含水磁罗脂作为纳米载体,用于同时化疗和光疗。通过UV /可见吸收,X射线衍射(XRD),透射电子显微镜(TEM)和超导量子干涉装置(鱿鱼)的特征在于核/壳纳米粒子。通过动态光散射(DLS)和TEM,表征磁性氧化物体。基于荧光的技术(FRET,稳态排放和各向异性)研究了这些纳米系统中的潜在抗肿瘤药物(噻吩吡啶衍生物)。芯/壳纳米粒子表现出25±2nm(来自TEM)的尺寸,等离子体吸收带(λmax= 550nm),并保持磁性。 XRD测量允许估计13.3nm直径用于锰铁氧体核心,11.7nm由于金壳。含水磁性氧化物,具有152±18nm的流体动力学直径,通过融合与模型膜相互作用,并且能够在脂质膜中运输抗肿瘤化合物,具有高封装效率(EE(%)= 98.4±0.8)。固体磁体胶质体表现出左右140nm的流体动力学直径,并成功携带抗癌药物(用EE(%)= 91.2±5.2),同时也是光疗的药剂。开发的多功能脂质体可以是用于组合化学/光疗法的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号